Physician profile
Judson B Moon
NPI 1447288790
$1,767.42
in general payments reported to CMS, 2019-2025
10 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $23.78 · 2021: $11.73 · 2022: $154 · 2023: $476 · 2024: $550 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,334.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $520.04 | 2022-2025 | Infuse, Miebo, Xiidra |
| Alcon Vision LLC | $222.02 | 2022-2025 | Total30, Precision7, Dailies Total1 |
| Coopervision INC. | $185.92 | 2020-2025 | Myday Contact Lens, Clariti Contact Lens |
| Rxsight INC | $167.21 | 2024-2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Johnson & Johnson Vision Care, INC. | $148.40 | 2019 | |
| Horizon Therapeutics Plc | $124.99 | 2023 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $118.09 | 2019-2021 | |
| Genzyme Corporation | $106.63 | 2024 | |
| Amgen INC. | $89.74 | 2024 | Tepezza |
| Sun Pharmaceutical Industries INC. | $84.38 | 2023 | Cequa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judson Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.